The general guideline development method is described at http://www.kdigo.org/ home/guidelines/development as well as below. OVERVIEW OF PROCESS The development process for the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease included the following steps: K Appointing Work Group members and the evidence review team (ERT) K Discussing process, methods, and results K Developing and refining topics K Identifying populations, interventions or predictors, and outcomes of interest K Selecting topics for systematic evidence review K Standardizing quality assessment methodology K Developing and implementing literature search strategies K Screening abstracts and retrieving full-text articles on the basis of pre-defined eligibility criteria K Creating data extraction forms K Extracting data and performing critical appraisal of the literature K Grading the methodology and outcomes in individual studies K Tabulating data from individual studies into summary tables K Grading quality of evidence for each outcome across studies, and assessing the overall quality of evidence across outcomes with the aid of evidence profiles K Grading the strength of recommendations on the basis of the quality of evidence and other considerations K Finalizing guideline recommendations and supporting rationales K Sending the guideline draft for peer review to the KDIGO Board of Directors in August 2012 and for public review in November 2012 K Editing the guideline K Publishing the final version of the guideline The Work Group Co-Chairs, KDIGO Co-Chairs and ERT met for a two-day meeting to go over the guideline develop- ment process, evidence review topics, and systematic review findings. Following this, the Work Group, KDIGO Co-Chairs and KDIGO support staff met held a two-day meeting to revisit the available evidence, formulate recommendation statements, deliberate on rationale for recommendations, and to develop consensus. 